Literature DB >> 26758845

Normal Molecular Specification and Neurodegenerative Disease-Like Death of Spinal Neurons Lacking the SNARE-Associated Synaptic Protein Munc18-1.

Chris Law1, Marcos Schaan Profes2, Martin Levesque2, Julia A Kaltschmidt3, Matthijs Verhage4, Artur Kania5.   

Abstract

The role of synaptic activity during early formation of neural circuits is a topic of some debate; genetic ablation of neurotransmitter release by deletion of the Munc18-1 gene provides an excellent model to answer the question of whether such activity is required for early circuit formation. Previous analysis of Munc18-1(-/-) mouse mutants documented their grossly normal nervous system, but its molecular differentiation has not been assessed. Munc18-1 deletion in mice also results in widespread neurodegeneration that remains poorly characterized. In this study, we demonstrate that the early stages of spinal motor circuit formation, including motor neuron specification, axon growth and pathfinding, and mRNA expression, are unaffected in Munc18-1(-/-) mice, demonstrating that synaptic activity is dispensable for early nervous system development. Furthermore, we show that the neurodegeneration caused by Munc18-1 loss is cell autonomous, consistent with apparently normal expression of several neurotrophic factors and normal GDNF signaling. Consistent with cell-autonomous degeneration, we demonstrate defects in the trafficking of the synaptic proteins Syntaxin1a and PSD-95 and the TrkB and DCC receptors in Munc18-1(-/-) neurons; these defects do not appear to cause ER stress, suggesting other mechanisms for degeneration. Finally, we demonstrate pathological similarities to Alzheimer's disease, such as altered Tau phosphorylation, neurofibrillary tangles, and accumulation of insoluble protein plaques. Together, our results shed new light upon the neurodegeneration observed in Munc18-1(-/-) mice and argue that this phenomenon shares parallels with neurodegenerative diseases. SIGNIFICANCE STATEMENT: In this work, we demonstrate the absence of a requirement for regulated neurotransmitter release in the assembly of early neuronal circuits by assaying transcriptional identity, axon growth and guidance, and mRNA expression in Munc18-1-null mice. Furthermore, we characterize the neurodegeneration observed in Munc18-1 mutants and demonstrate that this cell-autonomous process does not appear to be a result of defects in growth factor signaling or ER stress caused by protein trafficking defects. However, we find the presence of various pathological hallmarks of Alzheimer's disease that suggest parallels between the degeneration in these mutants and neurodegenerative conditions.
Copyright © 2016 the authors 0270-6474/16/360562-16$15.00/0.

Entities:  

Keywords:  Munc18-1; developmental; early neuronal activity; motor neurons; neurodegeneration; neurosecretion

Mesh:

Substances:

Year:  2016        PMID: 26758845      PMCID: PMC4710775          DOI: 10.1523/JNEUROSCI.1964-15.2016

Source DB:  PubMed          Journal:  J Neurosci        ISSN: 0270-6474            Impact factor:   6.167


  104 in total

1.  Co-expression of multiple transgenes in mouse CNS: a comparison of strategies.

Authors:  J L Jankowsky; H H Slunt; T Ratovitski; N A Jenkins; N G Copeland; D R Borchelt
Journal:  Biomol Eng       Date:  2001-06

2.  Cholinergic input is required during embryonic development to mediate proper assembly of spinal locomotor circuits.

Authors:  Christopher P Myers; Joseph W Lewcock; M Gartz Hanson; Simon Gosgnach; James B Aimone; Fred H Gage; Kuo-Fen Lee; Lynn T Landmesser; Samuel L Pfaff
Journal:  Neuron       Date:  2005-04-07       Impact factor: 17.173

Review 3.  Motor neuron trophic factors: therapeutic use in ALS?

Authors:  Thomas W Gould; Ronald W Oppenheim
Journal:  Brain Res Rev       Date:  2010-10-21

4.  Topographic organization of embryonic motor neurons defined by expression of LIM homeobox genes.

Authors:  T Tsuchida; M Ensini; S B Morton; M Baldassare; T Edlund; T M Jessell; S L Pfaff
Journal:  Cell       Date:  1994-12-16       Impact factor: 41.582

5.  Potentiation of developing synapses by postsynaptic release of neurotrophin-4.

Authors:  X H Wang; M M Poo
Journal:  Neuron       Date:  1997-10       Impact factor: 17.173

6.  GABRA1 and STXBP1: novel genetic causes of Dravet syndrome.

Authors:  Gemma L Carvill; Sarah Weckhuysen; Jacinta M McMahon; Corinna Hartmann; Rikke S Møller; Helle Hjalgrim; Joseph Cook; Eileen Geraghty; Brian J O'Roak; Steve Petrou; Alison Clarke; Deepak Gill; Lynette G Sadleir; Hiltrud Muhle; Sarah von Spiczak; Marina Nikanorova; Bree L Hodgson; Elena V Gazina; Arvid Suls; Jay Shendure; Leanne M Dibbens; Peter De Jonghe; Ingo Helbig; Samuel F Berkovic; Ingrid E Scheffer; Heather C Mefford
Journal:  Neurology       Date:  2014-03-12       Impact factor: 9.910

7.  In vivo activation of channelrhodopsin-2 reveals that normal patterns of spontaneous activity are required for motoneuron guidance and maintenance of guidance molecules.

Authors:  Ksenia V Kastanenka; Lynn T Landmesser
Journal:  J Neurosci       Date:  2010-08-04       Impact factor: 6.167

8.  Munc18-1 promotes large dense-core vesicle docking.

Authors:  T Voets; R F Toonen; E C Brian; H de Wit; T Moser; J Rettig; T C Südhof; E Neher; M Verhage
Journal:  Neuron       Date:  2001-08-30       Impact factor: 17.173

Review 9.  Mechanisms underlying inflammation in neurodegeneration.

Authors:  Christopher K Glass; Kaoru Saijo; Beate Winner; Maria Carolina Marchetto; Fred H Gage
Journal:  Cell       Date:  2010-03-19       Impact factor: 41.582

10.  A role for motoneuron subtype-selective ER stress in disease manifestations of FALS mice.

Authors:  Smita Saxena; Erik Cabuy; Pico Caroni
Journal:  Nat Neurosci       Date:  2009-03-29       Impact factor: 24.884

View more
  9 in total

1.  STXBP1 encephalopathies: Clinical spectrum, disease mechanisms, and therapeutic strategies.

Authors:  Debra Abramov; Noah Guy Lewis Guiberson; Jacqueline Burré
Journal:  J Neurochem       Date:  2020-08-04       Impact factor: 5.372

Review 2.  Defects at the crossroads of GABAergic signaling in generalized genetic epilepsies.

Authors:  Jing-Qiong Kang
Journal:  Epilepsy Res       Date:  2017-08-26       Impact factor: 3.045

Review 3.  Role of SNAREs in Neurodegenerative Diseases.

Authors:  Azzurra Margiotta
Journal:  Cells       Date:  2021-04-23       Impact factor: 6.600

4.  Beyond the SNARE: Munc18-1 chaperones α-synuclein.

Authors:  Mugdha Deshpande; Avital A Rodal
Journal:  J Cell Biol       Date:  2016-09-05       Impact factor: 10.539

5.  Munc18-1 is a molecular chaperone for α-synuclein, controlling its self-replicating aggregation.

Authors:  Ye Jin Chai; Emma Sierecki; Vanesa M Tomatis; Rachel S Gormal; Nichole Giles; Isabel C Morrow; Di Xia; Jürgen Götz; Robert G Parton; Brett M Collins; Yann Gambin; Frédéric A Meunier
Journal:  J Cell Biol       Date:  2016-09-05       Impact factor: 10.539

6.  Stxbp1/Munc18-1 haploinsufficiency impairs inhibition and mediates key neurological features of STXBP1 encephalopathy.

Authors:  Wu Chen; Zhao-Lin Cai; Eugene S Chao; Hongmei Chen; Colleen M Longley; Shuang Hao; Hsiao-Tuan Chao; Joo Hyun Kim; Jessica E Messier; Huda Y Zoghbi; Jianrong Tang; John W Swann; Mingshan Xue
Journal:  Elife       Date:  2020-02-19       Impact factor: 8.140

Review 7.  Vesicle trafficking and vesicle fusion: mechanisms, biological functions, and their implications for potential disease therapy.

Authors:  Lele Cui; Hao Li; Yufeng Xi; Qianli Hu; Huimin Liu; Jiaqi Fan; Yijuan Xiang; Xing Zhang; Weiwei Shui; Ying Lai
Journal:  Mol Biomed       Date:  2022-09-21

8.  Microwaves and Alzheimer's disease.

Authors:  Xia Zhang; Wen-Juan Huang; Wei-Wei Chen
Journal:  Exp Ther Med       Date:  2016-08-04       Impact factor: 2.447

9.  MUNC18-1 gene abnormalities are involved in neurodevelopmental disorders through defective cortical architecture during brain development.

Authors:  Nanako Hamada; Ikuko Iwamoto; Hidenori Tabata; Koh-Ichi Nagata
Journal:  Acta Neuropathol Commun       Date:  2017-11-30       Impact factor: 7.801

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.